Curis Lifesciences Limited (NSE:CURIS)
India · Delayed Price · Currency is INR 98.00
-6.00 (-5.77%)
At close: Feb 19, 2026
Curis Lifesciences Revenue
In the fiscal year ending March 31, 2025, Curis Lifesciences had annual revenue of 496.32M INR with 39.59% growth. Curis Lifesciences had revenue of 127.24M in the quarter ending March 31, 2025.
Revenue
496.32M
Revenue Growth
+39.59%
P/S Ratio
1.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
840.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 496.32M | 140.77M | 39.59% |
| Mar 31, 2024 | 355.56M | 1.07M | 0.30% |
| Mar 31, 2023 | 354.49M | 117.04M | 49.29% |
| Mar 31, 2022 | 237.45M | 24.85M | 11.69% |
| Mar 31, 2021 | 212.60M | 75.67M | 55.26% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hilton Metal Forging | 2.25B |
| Kaytex Fabrics | 1.53B |
| Graphisads | 1.36B |
| Silky Overseas | 1.18B |
| Paragon Fine And Speciality Chemical | 1.05B |
| Pattech Fitwell Tube Components | 592.86M |
| Invicta Diagnostic | 301.81M |
| Paramatrix Technologies | 288.32M |